MediciNova, Inc. (NASDAQ: MNOV)

MediciNova, Inc. (NASDAQ: MNOV), a biopharmaceutical company, is dedicated to acquiring and developing innovative, small-molecule therapeutics designed to treat diseases with medical needs that are currently unmet. By strategically forming alliances with other pharmaceutical companies, the company holds rights to a diversified portfolio of clinical and preclinical product candidates. MediciNova believes each of these candidates has a well-characterized and unique therapeutic profile, attractive commercial potential and patent assets having claims of commercially adequate scope. For further information, visit the Company’s web site at www.medicinova.com.